Innovaccer Expands into Public Sector to Facilitate More Equitable and Coordinated Care

2 years ago

Leading health cloud platform company assists public health case management, population health management and value-based analytics for Medicaid services SAN…

Anumana Collaborates with Leading Global Health Care Company to Detect Heart Disease Using Artificial Intelligence

2 years ago

Novartis Pharmaceuticals Corporation to collaborate on development of new medical device software for earlier detection and intervention in cardiovascular disease…

Model N Announces Date of Third Quarter Fiscal Year 2022 Financial Results

2 years ago

SAN MATEO, Calif.--(BUSINESS WIRE)--Model N, Inc. (MODN), a leader in revenue optimization and compliance, plans to announce financial results for…

Synchron Appoints Kurt Haggstrom as Chief Commercial Officer

2 years ago

NEW YORK--(BUSINESS WIRE)--Synchron, an endovascular brain-computer (BCI) interface company, today announced the appointment of Kurt Haggstrom as Chief Commercial Officer.…

Hologic Showcases Advances across the Continuum of Breast Health at ECR 2022

2 years ago

--Global Leader in Women's Health Highlights Importance of Timely and Accurate Diagnosis-- MARLBOROUGH, Mass.--(BUSINESS WIRE)--$HOLX #3DMammography--Hologic, Inc. (Nasdaq: HOLX) will…

Resaphene Suisse AG: FDA Approval Process for Tinnitus Therapy Tinniwell Continues

2 years ago

ROGGWIL, Switzerland--(BUSINESS WIRE)--Due to the COVID pandemic, work for the FDA approval of the tinniwell was stopped at the beginning…

Tebra Names Kevin Marasco as Chief Marketing Officer

2 years ago

SaaS Veteran to Lead Marketing Efforts for All-in-One Solution for Independent Practices NEWPORT BEACH, Calif.--(BUSINESS WIRE)--#EHR--Tebra, the digital backbone for…

Glaukos to Release Second Quarter 2022 Financial Results after Market Close on August 3

2 years ago

Conference Call and Webcast Scheduled for 1:30 p.m. PT ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology…

XVIVO Presents Interim Report January-June 2022

2 years ago

GOTHENBURG, SWEDEN / ACCESSWIRE / July 13, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Strong sales growth and increased gross marginsSecond quarter…

Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approved Prescription Drug for the Treatment of PKU

2 years ago

Company acquires an additional therapeutic product for the management of patients with PKU for worldwide markets, with the exception of…